---
title: "Cimetidine - Multiple Endocrine Neoplasia"
sidebar: mydoc_sidebar
permalink: db00501-mesh-d009377-1.html
toc: false 
---


Path ID: `DB00501_MESH_D009377_1`
{% include image.html url="images/db00501-mesh-d009377-1.png" file="db00501-mesh-d009377-1.png" alt="db00501-mesh-d009377-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D002927">MESH:D002927 </a> | Cimetidine | Drug |
| <a href="https://identifiers.org/UniProt:P25021">UniProt:P25021 </a> | Histamine H2 receptor | Protein |
| <a href="https://identifiers.org/GO:0035898">GO:0035898 </a> | parathyroid hormone secretion | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D009377">MESH:D009377 </a> | Multiple Endocrine Neoplasia | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cimetidine | DECREASES ACTIVITY OF | Histamine H2 Receptor |
| Histamine H2 Receptor | POSITIVELY REGULATES | Parathyroid Hormone Secretion |
| Parathyroid Hormone Secretion | POSITIVELY CORRELATED WITH | Multiple Endocrine Neoplasia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00501#mechanism-of-action](https://go.drugbank.com/drugs/DB00501#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Cimetidine](https://en.wikipedia.org/wiki/Cimetidine)
  - [https://www.uniprot.org/uniprot/P25021#function](https://www.uniprot.org/uniprot/P25021#function)
  - [https://pubmed.ncbi.nlm.nih.gov/7451639/](https://pubmed.ncbi.nlm.nih.gov/7451639/)
  - [https://en.wikipedia.org/wiki/Multiple_endocrine_neoplasia#Manifestations](https://en.wikipedia.org/wiki/Multiple_endocrine_neoplasia#Manifestations)
